Price as of · delayed, not real-time
Focused on the development, sale, and distribution of hemp-based cannabidiol (CBD) products, this company operates in the emerging cannabis wellness market. Investors monitor MJNA as one of the first publicly traded cannabis companies in the U.S., though its micro-cap status carries significant volatility risks.
1 member of Congress has disclosed 1 trade in Medical Marijuana, Inc. (MJNA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-02-05 | Marjorie Taylor Greene | sell | $1K – $15K |